[Laparoscopic Liver Resection for Liver Metastasis of Colorectal Cancer]

Gan To Kagaku Ryoho. 2022 Dec;49(13):1835-1837.
[Article in Japanese]

Abstract

The laparoscopic surgery is less invasive and better cosmetic. The laparoscopic liver resection(LLR)has been accepted for the insurance in April 2010, and increasingly performed in many hospitals, and also expected in metastasis of colorectal cancer. We retrospectively examined the results of LLR for liver metastasis of colorectal cancer. From June 2010 to July 2021, 174 cases of LLR for liver metastasis of colorectal cancer were performed in our hospital. The operation time was 384.5 minutes, the blood loss was small amount, and the postoperative hospital stay was 8 days. The complications were post-bleeding in 1 case, bile leakage in 7 cases, SSI in 16 cases, and no surgery-related deaths were observed. The 3-year disease-free survival rate was 22.8%, and the 5-year overall survival rate was 53.3%. In the comparison between single LLR and multiple LLR, the operation time and the blood loss increased, but there was no significant difference in the length of postoperative hospital stay. In initial LLR and repeat LLR, there were no significant differences in the operation time, blood loss, and postoperative hospital stay. In the primary lesion and simultaneous LLR and heterochronous LLR, the operation time and blood loss were not significantly different, but postoperative intra-abdominal abscess and SSI were more happened, and the postoperative hospital stay was significantly extended. LLR for liver metastasis of colorectal cancer can be safely performed at multiple sites or multiple times, and good treatment results have been obtained, so it was considered to be an effective treatment method.

Publication types

  • English Abstract

MeSH terms

  • Carcinoma, Hepatocellular* / surgery
  • Colorectal Neoplasms* / pathology
  • Colorectal Neoplasms* / surgery
  • Hepatectomy / methods
  • Humans
  • Laparoscopy* / methods
  • Length of Stay
  • Liver Neoplasms* / secondary
  • Postoperative Complications
  • Retrospective Studies

Substances

  • 3-aminolevamisole